PMID- 32025447 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 2168-8184 (Print) IS - 2168-8184 (Electronic) IS - 2168-8184 (Linking) VI - 12 IP - 1 DP - 2020 Jan 27 TI - Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis. PG - e6790 LID - 10.7759/cureus.6790 [doi] LID - e6790 AB - Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (CLE). It is characterized by the presence of a chronic inflammatory process involving the deep dermis and subcutaneous tissues. It commonly presents as deep indurated nodules or sharply demarcated plaques. Antimalarial medications are considered first-line therapy for most cases of LEP while systemic corticosteroids are saved for more resistant lesions. Intravenous immunoglobulin (IVIG) is made up of concentrated polyclonal immunoglobulin G (IgG) fractionated from the blood of healthy blood donors. Nowadays, it is used for the treatment of numerous autoimmune and systemic inflammatory diseases. In this case, we report the case of a female with multiple LEP and discoid lupus erythematosus (DLE) lesions refractory to multiple standard therapy modalities that responded dramatically to IVIG. CI - Copyright (c) 2020, AlQadri et al. FAU - AlQadri, Nada G AU - AlQadri NG AD - Department of Dermatology, Alfaisal University College of Medicine, Riyadh, SAU. FAU - AlNooh, Bayan AU - AlNooh B AD - Department of Dermatology, King Khalid University Hospital, Riyadh, SAU. FAU - AlTewerki, Malak M AU - AlTewerki MM AD - Department of Neuroscience, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU. FAU - Almotairi, Ahmad AU - Almotairi A AD - Department of Pathology, King Saud University Medical City, Riyadh, SAU. FAU - Alajlan, Saad AU - Alajlan S AD - Department of Dermatology, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU. LA - eng PT - Case Reports DEP - 20200127 PL - United States TA - Cureus JT - Cureus JID - 101596737 PMC - PMC6988482 OTO - NOTNLM OT - chronic cutaneous lupus OT - cutaneous lupus OT - intravenous immunoglobulin OT - ivig OT - lupus OT - lupus erythematosus panniculitis OT - lupus erythematosus profundus OT - sle COIS- The authors have declared that no competing interests exist. EDAT- 2020/02/07 06:00 MHDA- 2020/02/07 06:01 PMCR- 2020/01/27 CRDT- 2020/02/07 06:00 PHST- 2020/02/07 06:00 [entrez] PHST- 2020/02/07 06:00 [pubmed] PHST- 2020/02/07 06:01 [medline] PHST- 2020/01/27 00:00 [pmc-release] AID - 10.7759/cureus.6790 [doi] PST - epublish SO - Cureus. 2020 Jan 27;12(1):e6790. doi: 10.7759/cureus.6790.